Published Date: 05 Apr 2023
Almost one in five adults in America has diabetes. The common condition is not, however, easy to manage or treat. The No. 1 cause of death worldwide is diabetes and its complications. One of the main causes of lower-limb and adult blindness.
Read Full NewsThe largest randomized study of a multicancer blood test found no reduction in late-stage cancers, while raising new questions about stage shift, mortality benefit, and population screening.
Interim findings from the phase 3 MonumenTAL-3 trial highlight overall and progression-free survival as well as response rates compared with standard therapy.
1.
HER2 ADC Shows Promise in Recurrent Endometrial Cancer
2.
Pressing the Sleep button could have a positive impact on cognition.
3.
These Medical Doctors Are Real Comedians: Should Doctors Be Funnier?
4.
Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer
5.
Chemoradiation Plus Immunotherapy Fails to Improve Survival in Limited-Stage SCLC
1.
How Cancer Cells Evade Immune Destruction and the Fight Back
2.
Exploring Innovative Approaches to Esophageal Cancer Treatment
3.
Hepatocellular Carcinoma: Emerging Trends and Innovations in Diagnosis and Management
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Uncovering New Hope for Follicular Lymphoma Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
4.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation